X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
interleukin-12/23 monoclonal-antibody (642) 642
double-blind (494) 494
humans (487) 487
index medicus (466) 466
psoriasis (380) 380
dermatology (286) 286
ustekinumab (266) 266
psoriasis - drug therapy (253) 253
placebo-controlled trial (220) 220
safety (192) 192
efficacy (187) 187
to-severe psoriasis (155) 155
male (150) 150
female (148) 148
antibodies, monoclonal - therapeutic use (146) 146
animals (132) 132
treatment outcome (132) 132
adult (118) 118
middle aged (115) 115
rheumatoid-arthritis (106) 106
randomized controlled-trial (105) 105
immunology (104) 104
pharmacology & pharmacy (98) 98
etanercept (95) 95
severity of illness index (92) 92
phase-iii (88) 88
chronic plaque psoriasis (84) 84
psoriasis - immunology (84) 84
severe plaque psoriasis (84) 84
quality-of-life (83) 83
drug therapy (82) 82
care and treatment (81) 81
antibodies, monoclonal, humanized (76) 76
moderate (76) 76
dermatologic agents - therapeutic use (75) 75
antibodies, monoclonal - adverse effects (66) 66
infliximab (66) 66
cytokines (64) 64
plaque psoriasis (64) 64
analysis (63) 63
tumor necrosis factor-alpha - antagonists & inhibitors (63) 63
clinical trials (61) 61
psoriasis - pathology (61) 61
psoriasis - therapy (60) 60
dermatologic agents (59) 59
adalimumab (58) 58
antibodies, monoclonal, humanized - therapeutic use (58) 58
formulae, receipts, prescriptions (58) 58
monoclonal antibodies (58) 58
arthritis (57) 57
psoriatic arthritis (56) 56
necrosis-factor-alpha (55) 55
biological products - therapeutic use (53) 53
inflammation (52) 52
biologics (49) 49
double-blind method (49) 49
il-23 (49) 49
crohn's disease (47) 47
research (47) 47
skin (47) 47
therapy (47) 47
trial (47) 47
inflammatory-bowel-disease (46) 46
aged (45) 45
dendritic cells (44) 44
interleukins (44) 44
rheumatology (44) 44
interleukin-23 - antagonists & inhibitors (43) 43
maintenance therapy (43) 43
t cells (43) 43
medicine, research & experimental (42) 42
risk factors (42) 42
abridged index medicus (41) 41
controlled-trial (41) 41
crohns-disease (41) 41
infliximab induction (41) 41
interleukin-23 - immunology (41) 41
quality of life (41) 41
medicine, general & internal (40) 40
phase-iii trial (40) 40
health aspects (39) 39
randomized controlled trials as topic (39) 39
th17 cells (39) 39
arthritis, psoriatic - drug therapy (38) 38
clinical trials as topic (38) 38
mice (38) 38
th17 cells - immunology (38) 38
tumor-necrosis-factor (38) 38
long-term safety (37) 37
review (37) 37
t-cells (37) 37
immunologic factors - therapeutic use (36) 36
medicine & public health (35) 35
cytokine (34) 34
genome-wide association (34) 34
ustekinumab - therapeutic use (34) 34
collagen-induced arthritis (33) 33
dermatologic agents - administration & dosage (33) 33
dose-response relationship, drug (33) 33
gastroenterology & hepatology (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (641) 641
French (6) 6
German (4) 4
Portuguese (3) 3
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
AMERICAN JOURNAL OF PATHOLOGY, ISSN 0002-9440, 07/2012, Volume 181, Issue 1, pp. 8 - 18
Th17 cells that secrete the cytokines IL-17A and IL-17F and express lineage-specific transcription factor RORC (ROR gamma t in mice) represent a distinct... 
RHEUMATOID-ARTHRITIS | GROWTH-FACTOR-BETA | TGF-BETA | ROR-GAMMA-T | IN-VIVO | INTRAVENOUS IMMUNOGLOBULIN THERAPY | T(H)17 DEVELOPMENT | CENTRAL-NERVOUS-SYSTEM | PATHOLOGY | AUTOIMMUNE ENCEPHALOMYELITIS | INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY
Journal Article
JOURNAL OF DRUGS IN DERMATOLOGY, ISSN 1545-9616, 07/2015, Volume 14, Issue 7, pp. 58 - 66
Background: Safety surveillance is needed for biologic therapies for psoriasis. Objective: To assess the risk of adverse events of special interest (AEoSIs)... 
RHEUMATOID-ARTHRITIS | TO-SEVERE PSORIASIS | DISEASE-BASED REGISTRY | EFFICACY | CARDIOVASCULAR EVENTS | PLAQUE PSORIASIS | LONG-TERM SAFETY | BIOLOGIC THERAPIES | DOUBLE-BLIND | INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY | DERMATOLOGY
Journal Article
JOURNAL OF DRUGS IN DERMATOLOGY, ISSN 1545-9616, 08/2018, Volume 17, Issue 8, pp. 873 - 879
Background: Toreforant is a selective histamine H-4 receptor antagonist. w receptor activation may play a role in immune-mediated inflammation in psoriasis.... 
CELLS | THERAPY | USTEKINUMAB | INFLIXIMAB INDUCTION | INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY | DERMATOLOGY
Journal Article
Journal Article
by de Beaucouey, Ludovic and Samarina, Arina and Bustamante, Jacinta and Cobat, Aurelie and Boisson-Dupuis, Stephanie and Feinberg, Jacqueline and Al-Muhsen, Saleh and Janniere, Lucile and Rose, Yoann and de Suremain, Maylis and Kong, Xiao-Fei and Filipe-Santos, Orchidee and Chapgier, Ariane and Picard, Capucine and Fischer, Alain and Dogu, Figen and Ikinciogullari, Aydan and Tanir, Gonul and Al-Hajjar, Sami and Al-Jumaah, Suliman and Frayha, Husn H and Alsum, Zobaida and Al-Ajaji, Sulaiman and Alangari, Abdullah and Al-Ghonaium, Abdulaziz and Adimi, Parisa and Mansouri, Davood and Ben-Mustapha, Imen and Yancoski, Judith and Garty, Ben-Zion and Roiguez-Gallego, Carlos and Caragol, Isabel and Kutukculer, Necil and Kumararatne, Dinakantha S and Patel, Smita and Doffinger, Rainer and Exley, Anew and Jeppsson, Olle and Reichenbach, Janine and Nadal, David and Boyko, Yaryna and Pietrucha, Barbara and Anderson, Suzanne and Levin, Michael and Schandene, Liliane and Schepers, Kinda and Efira, Ane and Mascart, Francoise and Matsuoka, Masao and Sakai, Tatsunori and Siegrist, Claire-Anne and Frecerova, Klara and Blueetters-Sawatzki, Renate and Bernhoeft, Jutta and Freihorst, Joachim and Baumann, Ulrich and Richter, Darko and Haerynck, Filomeen and De Baets, Frans and Novelli, Vas and Lammas, David and Vermylen, Christiane and Tuerlinckx, David and Nieuwhof, Chris and Pac, Malgorzata and Haas, Walther H and Mueller-Fleckenstein, Ingrid and Fleckenstein, Bernhard and Levy, Jacob and Raj, Revathi and Cohen, Aileen Cleary and Lewis, David B and Holland, Steven M and Yang, Kuender D and Wang, Xiaochuan and Wang, Xiaohong and Jiang, Liping and Yang, Xiqiang and Zhu, Chaomin and Xie, Yuanyuan and Lee, Pamela Pui Wah and Chan, Koon Wing and Chen, Tong-Xin and Castro, Gabriela and Natera, Ivelisse and Codoceo, Ana and King, Alejana and Bezrodnik, Liliana and Di Giovani, Daniela and Isabel Gaillard, Maria and de Moraes-Vasconcelos, Dewton and Grumach, Anete Sevciovic and da Silva Duarte, Alberto Jose and Aldana, Ruth and Javier Espinosa-Rosales, Francisco and Bejaoui, Mohammed and Bousfiha, Ahmed Aziz and El Baghdadi, Jamila and Ozbek, Namik and Aksu, Guzide and ...
Medicine, ISSN 0025-7974, 11/2010, Volume 89, Issue 6, pp. 381 - 402
Interleukin-12 receptor beta 1 (IL-12R beta 1) deficiency is the most common form of Mendelian susceptibility to mycobacterial disease (MSMD). We undertook an... 
MEDICINE, GENERAL & INTERNAL | INTERFERON-GAMMA RECEPTOR | CALMETTE-GUERIN INFECTION | RECEPTOR BETA-1 DEFICIENCY | IFN-GAMMA | HOST-DEFENSE | GENETIC-HETEROGENEITY | MYCOBACTERIUM-AVIUM INFECTION | CLINICAL-FEATURES | INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY | T-HELPER-CELLS | Life Sciences
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 73, Issue 3, pp. 400 - 409
Journal Article